.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Teva
Moodys
McKinsey
Cantor Fitzgerald
Chinese Patent Office
Argus Health
Express Scripts
Accenture
Federal Trade Commission

Generated: February 25, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: darifenacin hydrobromide

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Macleods Pharms LtdDARIFENACINdarifenacin hydrobromideTABLET, EXTENDED RELEASE;ORAL207302ANDAMacleods Pharmaceuticals LimitedN33342-276-12
Macleods Pharms LtdDARIFENACINdarifenacin hydrobromideTABLET, EXTENDED RELEASE;ORAL207302ANDAMacleods Pharmaceuticals LimitedN33342-276-10
Macleods Pharms LtdDARIFENACINdarifenacin hydrobromideTABLET, EXTENDED RELEASE;ORAL207302ANDAMacleods Pharmaceuticals LimitedN33342-276-07
Macleods Pharms LtdDARIFENACINdarifenacin hydrobromideTABLET, EXTENDED RELEASE;ORAL207302ANDAMacleods Pharmaceuticals LimitedN33342-277-12
Macleods Pharms LtdDARIFENACINdarifenacin hydrobromideTABLET, EXTENDED RELEASE;ORAL207302ANDAMacleods Pharmaceuticals LimitedN33342-277-07
Macleods Pharms LtdDARIFENACINdarifenacin hydrobromideTABLET, EXTENDED RELEASE;ORAL207302ANDAMacleods Pharmaceuticals LimitedN33342-277-10
Alembic Pharms LtdDARIFENACIN HYDROBROMIDEdarifenacin hydrobromideTABLET, EXTENDED RELEASE;ORAL207681ANDAAlembic Pharmaceuticals LimitedN46708-223-90
Alembic Pharms LtdDARIFENACIN HYDROBROMIDEdarifenacin hydrobromideTABLET, EXTENDED RELEASE;ORAL207681ANDAAlembic Pharmaceuticals LimitedN46708-223-30
Alembic Pharms LtdDARIFENACIN HYDROBROMIDEdarifenacin hydrobromideTABLET, EXTENDED RELEASE;ORAL207681ANDAAlembic Pharmaceuticals LimitedN46708-223-08
Alembic Pharms LtdDARIFENACIN HYDROBROMIDEdarifenacin hydrobromideTABLET, EXTENDED RELEASE;ORAL207681ANDAAlembic Pharmaceuticals LimitedN46708-223-91
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Dow
Merck
Argus Health
Mallinckrodt
Healthtrust
Covington
Colorcon
QuintilesIMS
Johnson and Johnson

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot